Report ID: SQMIG35H2240
Report ID:
SQMIG35H2240 |
Region:
Global |
Published Date: February, 2024
Pages:
219
|
Tables:
117 |
Figures:
77
North America held the highest revenue in 2022. This can be attributed to the presence of many important market participants offering gene synthesis services, as well as the increased interest of large biotechnology and pharmaceutical businesses in gene and cell technologies therapy development, the region's expanding field of synthetic biology, and growing interest in gene production in the molecular biology arena.
Asia Pacific is expected to grow at the quickest rate over the forecast period, owing to increased research activities for the creation of effective treatments, as well as increased interest in the field of synthetic biology research. Furthermore, disease incidence is increasing as a result of lifestyle changes. Improving healthcare infrastructure, the arrival of significant biotechnology organizations, and increased R&D efforts are all likely to contribute to market expansion.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2240